Algo version: 0.98b
Biofil Chemicals and is listed at the NSE Exchange
Biofil Chemicals and [BIOFILCHEM.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Biofil Chemicals and stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biofil Chemicals and 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR5.20, you would have made a profit of INR60.19 per share or 1 157.50%

Yes, the average daily trading liquidity for Biofil Chemicals and is INR75 567 thousand. You should therefore be able to get in and out of your positions relatively fast.

Biofil Chemicals and has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.96, the company's ability to pay off the debt is good. The company has a very low net profit margin of 1.77%, which is challenging.

We have calculated the inflation risk for Biofil Chemicals and to be low [0.2 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.